scispace - formally typeset
T

Terese C. Hammond

Researcher at Missouri University of Science and Technology

Publications -  9
Citations -  373

Terese C. Hammond is an academic researcher from Missouri University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 4 publications receiving 350 citations.

Papers
More filters
Journal ArticleDOI

In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso-2,3-Dimercaptosuccinic Acid or N-acetylcysteine

TL;DR: Results suggest that lead-induced oxidative stress in vivo can be mitigated by pharmacologic interventions, which encompass both chelating as well as thiol-mediated antioxidant functions.
Journal ArticleDOI

A role for oxidative stress in suppressing serum immunoglobulin levels in lead-exposed Fisher 344 rats.

TL;DR: It is suggested that oxidative stress contributes to suppressed serum Ig levels during lead intoxication in vivo, and that intervention with either a thiol antioxidant (NAC) or a metal chelator (DMSA) will alleviate this lead-induced suppression by correcting the prooxidant/antioxidant imbalance caused by lead exposure.
Journal ArticleDOI

N-acetylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress

TL;DR: The results suggest that NAC can confer protection against lead-induced oxidative stress to CHO cells, possibly through the enhancement of the cell’s own antioxidant defense mechanisms.
Journal ArticleDOI

High-performance liquid chromatography assay for N-acetylcysteine in biological samples following derivatization with N-(1-pyrenyl)maleimide

TL;DR: A sensitive, rapid method for determining reduced N-acetylcysteine (NAC) concentration in biological samples has been developed which uses a modified reversed-phase high-performance liquid chromatography technique in conjunction with the derivatizing agent N-(1-pyrenyl)maleimide (NPM).
ReportDOI

Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001

TL;DR: In this article , two critically ill COVID-19 infected patients, who had exhausted all available treatment options, were treated with the small-molecule RRx-001 with subsequent improvement.